What is the significance of the 7,490-share grant reported by BioMarin (BMRN)?

The 7,490 shares represent a restricted stock unit grant made on June 2, 2026, as compensation to director Timothy P. Walbert. Such grants are common for board members and increase his direct ownership stake without requiring cash outlay.

BioMarin (NASDAQ: BMRN) director receives 7,490-share RSU grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

BioMarin Pharmaceutical director Timothy P. Walbert reported an equity grant of 7,490 shares of common stock on June 2, 2026. The shares were received as restricted stock units granted on that date, with no purchase price involved, reflecting stock-based compensation rather than an open‑market trade.

Following the grant, Walbert directly holds 17,270 shares of BioMarin common stock. In addition, 416 shares are reported as indirectly held through Prairie Capital Ventures LLC. The filing does not show any sales or option exercises, only this award and an updated indirect holding line.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Walbert Timothy P

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,490	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 17,270 shares (Direct, null); Common Stock — 416 shares (Indirect, Shares held by Prairie Capital Ventures LLC)

Footnotes (1)

[object Object]

Key Figures

RSU grant size: 7,490 shares Direct holdings after grant: 17,270 shares Indirect holdings: 416 shares +2 more

5 metrics

RSU grant size 7,490 shares Restricted stock units granted on June 2, 2026

Direct holdings after grant 17,270 shares Common stock held directly after June 2, 2026 grant

Indirect holdings 416 shares Common stock held indirectly via Prairie Capital Ventures LLC

Grant price per share $0.00 per share Restricted stock units; price not applicable per footnote

Grant date June 2, 2026 Date restricted stock units were granted

Key Terms

Restricted stock units, grant/award acquisition, indirect ownership, Form 4

4 terms

Restricted stock units financial

"Restricted stock units granted on June 2, 2026. Price not applicable."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

grant/award acquisition financial

"transaction_action: grant/award acquisition, transaction_code_description: Grant, award, or other acquisition"

indirect ownership financial

"direct_or_indirect: I, nature_of_ownership: Shares held by Prairie Capital Ventures LLC"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/04/2026 - 06:09 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walbert Timothy P

(Last)

(First)

(Middle)

C/O BIOMARIN PHARMACEUTICAL INC.

770 LINDARO STREET

(Street)

SAN RAFAEL

CALIFORNIA

94901

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/02/2026		A		7,490	A	$0⁽¹⁾	17,270	D
Common Stock								416	I	Shares held by Prairie Capital Ventures LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock units granted on June 2, 2026. Price not applicable.

Remarks:

	/s/ Tae Sang Yoo, Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did BioMarin (BMRN) director Timothy P. Walbert report in this Form 4?

He reported receiving 7,490 shares of BioMarin common stock as a restricted stock unit grant on June 2, 2026. This is a stock-based compensation award, not an open-market purchase or sale, and updates his reported share ownership.

How many BioMarin (BMRN) shares does Timothy P. Walbert hold after the reported grant?

After the grant, he directly holds 17,270 shares of BioMarin common stock. The filing also shows 416 additional shares held indirectly through Prairie Capital Ventures LLC, providing a snapshot of his total reported equity exposure.

Was the BioMarin (BMRN) Form 4 transaction a stock purchase or sale?

The filing does not show any open-market purchase or sale. Instead, it records an acquisition of 7,490 shares as a restricted stock unit grant, labeled as a grant or award acquisition, with a transaction price of $0.00 per share.

How are the indirect BioMarin (BMRN) shares held for Timothy P. Walbert structured?

The Form 4 shows 416 BioMarin common shares held indirectly, with ownership attributed to Prairie Capital Ventures LLC. This indicates those shares are owned through that entity rather than personally, while still being reportable for beneficial ownership purposes.